Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-12

Clinical Trial Update: A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Updated results from a Phase 3 trial comparing tocilizumab as monotherapy and in combination with methotrexate versus methotrexate alone in early rheumatoid art…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Actemra (tocilizumab)
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2013-07-12